Literature DB >> 33888735

Hyperoxia-activated circulating extracellular vesicles induce lung and brain injury in neonatal rats.

Anum Ali1, Ronald Zambrano1, Matthew R Duncan1, Shaoyi Chen1, Shihua Luo1, Huijun Yuan1, Pingping Chen1, Merline Benny1, Augusto Schmidt1, Karen Young1, Nadine Kerr2,3, Juan Pablo de Rivero Vaccari2,3, Robert W Keane2,3, W Dalton Dietrich2, Shu Wu4.   

Abstract

Hyperoxia-induced lung injury plays a key role in the development of bronchopulmonary dysplasia (BPD), characterized by inflammatory injury and impaired lung development in preterm infants. Although BPD is a predictor of poor neurodevelopmental outcomes, currently it is uncertain how lung injury contributes to brain injury in preterm infants. Extracellular vesicles (EVs) are a heterogeneous group of cell-derived membranous structures that regulate intercellular and inter-organ communications. Gasdermin D (GSDMD) has emerged as a key executor of inflammasome-mediated cell death and inflammation. In this study, we utilized a neonatal rat model of BPD to assess if hyperoxia stimulates lung release of circulating EVs and if these EVs induce lung and brain injury. We found that hyperoxia-exposed rats had elevated numbers of plasma-derived EVs compared to rats maintained in room air. These EVs also had increased cargos of surfactant protein C, a marker of type II alveolar epithelial cells (AEC), and the active (p30) form of GSDMD. When these EVs were adoptively transferred into normal newborn rats via intravenous injection, they were taken up both by lung and brain tissues. Moreover, EVs from hyperoxic animals induced not only the pathological hallmarks of BPD, but also brain inflammatory injury in recipient rats, as well as inducing cell death in cultured pulmonary vascular endothelial cells and neural stem cells (NSC). Similarly, hyperoxia-exposed cultured AEC-like cells released EVs that also contained increased GSDMD-p30 and these EVs induced pyroptotic cell death in NSC. Overall, these data indicate that hyperoxia-activated circulating EVs mediate a lung to brain crosstalk resulting in brain injury and suggest a mechanism that links lung injury and neurodevelopmental impairment in BPD infants.

Entities:  

Year:  2021        PMID: 33888735     DOI: 10.1038/s41598-021-87706-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  44 in total

1.  Bronchopulmonary dysplasia.

Authors:  A H Jobe; E Bancalari
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

Review 2.  Membrane vesicles as conveyors of immune responses.

Authors:  Clotilde Théry; Matias Ostrowski; Elodie Segura
Journal:  Nat Rev Immunol       Date:  2009-06-05       Impact factor: 53.106

Review 3.  Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances.

Authors:  Joseph J Volpe
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

4.  Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation.

Authors:  Ankur Kulshreshtha; Tanveer Ahmad; Anurag Agrawal; Balaram Ghosh
Journal:  J Allergy Clin Immunol       Date:  2013-02-14       Impact factor: 10.793

5.  Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.

Authors:  Barbara Schmidt; Elizabeth V Asztalos; Robin S Roberts; Charlene M T Robertson; Reginald S Sauve; Michael F Whitfield
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

Review 6.  Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers.

Authors:  Alexander G Thompson; Elizabeth Gray; Sabrina M Heman-Ackah; Imre Mäger; Kevin Talbot; Samir El Andaloussi; Matthew J Wood; Martin R Turner
Journal:  Nat Rev Neurol       Date:  2016-05-13       Impact factor: 42.937

Review 7.  Neurodevelopmental outcome of bronchopulmonary dysplasia.

Authors:  Peter J Anderson; Lex W Doyle
Journal:  Semin Perinatol       Date:  2006-08       Impact factor: 3.300

8.  Bronchopulmonary Dysplasia: Executive Summary of a Workshop.

Authors:  Rosemary D Higgins; Alan H Jobe; Marion Koso-Thomas; Eduardo Bancalari; Rose M Viscardi; Tina V Hartert; Rita M Ryan; Suhas G Kallapur; Robin H Steinhorn; Girija G Konduri; Stephanie D Davis; Bernard Thebaud; Ronald I Clyman; Joseph M Collaco; Camilia R Martin; Jason C Woods; Neil N Finer; Tonse N K Raju
Journal:  J Pediatr       Date:  2018-03-16       Impact factor: 4.406

9.  Cognitive Development and Quality of Life Associated With BPD in 10-Year-Olds Born Preterm.

Authors:  Sudhir Sriram; Michael D Schreiber; Michael E Msall; Karl C K Kuban; Robert M Joseph; T Michael O' Shea; Elizabeth N Allred; Alan Leviton
Journal:  Pediatrics       Date:  2018-05-17       Impact factor: 7.124

Review 10.  Pulmonary Extracellular Vesicles as Mediators of Local and Systemic Inflammation.

Authors:  Casper J E Wahlund; Anders Eklund; Johan Grunewald; Susanne Gabrielsson
Journal:  Front Cell Dev Biol       Date:  2017-04-26
View more
  3 in total

Review 1.  Placental mediated mechanisms of perinatal brain injury: Evolving inflammation and exosomes.

Authors:  Alexander R Gall; Stephen Amoah; Yuma Kitase; Lauren L Jantzie
Journal:  Exp Neurol       Date:  2021-11-06       Impact factor: 5.330

2.  Circulating extracellular vesicles activate the pyroptosis pathway in the brain following ventilation-induced lung injury.

Authors:  Laura Chavez; Julia Meguro; Shaoyi Chen; Vanessa Nunes de Paiva; Ronald Zambrano; Julia M Eterno; Rahul Kumar; Matthew R Duncan; Merline Benny; Karen C Young; W Dalton Dietrich; Roberta Brambilla; Shu Wu; Augusto F Schmidt
Journal:  J Neuroinflammation       Date:  2021-12-29       Impact factor: 8.322

Review 3.  Perinatal Hyperoxia and Developmental Consequences on the Lung-Brain Axis.

Authors:  Stefanie Obst; Josephine Herz; Miguel A Alejandre Alcazar; Stefanie Endesfelder; Marius A Möbius; Mario Rüdiger; Ursula Felderhoff-Müser; Ivo Bendix
Journal:  Oxid Med Cell Longev       Date:  2022-02-24       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.